Cheviot Value Management
LIMN icon

Cheviot Value Management’s Liminatus Pharma LIMN Stock Holding History

Cheviot Value Management’s Portfolio LIMN Stock Details LIMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$373 Buy
+100
New +$504 ﹤0.01% 495

Other funds holding LIMN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Cheviot Value Management's LIMN Position: Q3 2026 in Review

Cheviot Value Management opened a new position in Liminatus Pharma (LIMN) in Q3 2026: 100 shares worth $373. The stake represents ﹤0.01% of the portfolio and ranks #495 among its holdings.

3 funds tracked by Wall St. Rank hold LIMN as of Q3 2026.

  • Cheviot Value Management held 100 shares of Liminatus Pharma worth $373 as of Q3 2026.
  • Liminatus Pharma was a new Cheviot Value Management position in Q3 2026.
  • Liminatus Pharma made up ﹤0.01% of Cheviot Value Management's portfolio in Q3 2026, its #495 holding.
  • 3 funds tracked by Wall St. Rank held Liminatus Pharma as of Q3 2026.

Based on Cheviot Value Management's 13F filing for Q3 2026, filed 9 Nov 2026.